Sumitomo Pharma America Holdings Inc.

We are dedicated to improving the health and well-being of patients in Canada through innovative treatments curated by cutting-edge science and technology dedicated to improving the health and well-being of people around the world through innovative science and technology. Sumitomo Pharma Canada is a Sumitomo Pharma America (SMPA) company. You are now leaving ca.sumitomo-pharma.com and moving to an external web site that is independently maintained by a third party. You are now leaving ca.sumitomo-pharma.com and are being directed to us.sumitomo-pharma.com. Dedicated to improving the health and well-being of people living with serious medical conditions. Sumitomo Pharma Canada (SMPCA) is an innovative and entrepreneurial health care company that commercializes prescription products in Canada. We are united in our mission to deliver patient-needed therapies in Canada sooner. SMPCA is a Sumitomo Pharma America (SMPA) company.

We are united in our mission to deliver patient-needed therapies sooner. Biopharma business, including Specialty and Oncology business units. You are now leaving us.sumitomo-pharma.com and moving to an external web site that is independently maintained by a third party. SMPA is committed to accelerating scientific and therapeutic breakthroughs on behalf of patients in critical disease areas across psychiatry & neurology, oncology, urology, women’s health, rare disease, and cell & gene therapies. Our parent company, Sumitomo Pharma Co., Ltd., was established in 1897 and has an extensive history of supporting health and wellbeing. Sumitomo Pharma is a member of the Sumitomo Group, which has a history of about 400 years. Prior to Pfizer, Adele held Vice President roles within AstraZeneca, including leading business development/innovation and design for launch brands as well as the multi-billion-dollar Cardiovascular business unit. From 2001 to 2009, Joan held various leadership roles at Merck Research Laboratories, including in research, drug development and business development.

Through our services, we help you to grow so that you can bring about a positive impact on global health. We are specialized in providing solutions, resources, expertise, and talent to our customers in a timely and cost-effective manner. We are passionate about and dedicated to building a diverse and inclusive consulting experience. Our Mission: Our mission is to amalgamate technical and scientific knowledge with due diligence to deliver the high-quality scientific services. Our Vision: Our Vision is to provide the latest and effective technical services combined with innovative solutions that will make a difference in the life of our people’s business and the safety of their customers. Our Goal: Our goal is to meet the set standards of excellence of our people which includes clients, employees, candidates, and those of our community and give all what it takes to satisfy the world’s ever-evolving demand for technology for patient safety. Our service areas share a foundation of deep scientific expertise and analytic rigor. We deliver innovative and sustainable results through our collaborative approach across the Life Sciences and IT Industries.

Collaborate With PurposeWe are greater than the sum of our parts. We are determined to discover, develop and deliver new possibilities for patients. We are committed to unlocking fundamentally different therapeutic approaches and creating new solutions through bold science and our unique drug discovery platform. We are on a mission to discover, develop, and deliver life-changing therapies. We discover, develop, and deliver life-changing therapies by harnessing cutting-edge science to create new possibilities for people with serious diseases that have high unmet need. Improving lives is the foundation of our values and our ultimate endpoint. Focus on the PatientWe champion what matters to patients and their families. Uphold High StandardsWe strive for excellence by acting with integrity, delivering high quality, and operating with accountability in our work and with each other.

Drug discovery, development, and commercialization must become faster and more efficient to address humanity’s health needs. Sumitovant embodies the bold promise of combining technology and life-sciences expertise to drive innovation. Our portfolio includes marketed products and a robust investigational pipeline addressing unmet patient needs in pediatrics, urology, oncology, women’s health, specialty respiratory and infectious diseases. We are next-generation biopharma innovating for patient-first outcomes through an agile approach that centers on the patient throughout. Formed in 2019, Sumitovant was founded through the strategic alliance between Roivant Sciences and Sumitomo Pharma, our parent company based in Japan.

Driven by a passion to help patients, the company collaborates with the world’s leading clinicians and researchers to address unmet healthcare needs, working to improve patient outcomes and enhance lives. Through our actions, we will become trusted partners with customers, colleagues, and patients — creating a community unified in its mission to improve the quality of life around the world.